{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:59:21Z","timestamp":1762505961045},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.eururo.2012.08.003","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T22:00:46Z","timestamp":1344636046000},"page":"792-796","source":"Crossref","is-referenced-by-count":73,"title":["18F-Fluoroethylcholine PET\/CT Identifies Lymph Node Metastasis in Patients with Prostate-Specific Antigen Failure After Radical Prostatectomy but Underestimates Its Extent"],"prefix":"10.1016","volume":"63","author":[{"given":"Derya","family":"Tilki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Reich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anno","family":"Graser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Silchinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin J.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"Khoder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bartenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian G.","family":"Stief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Loidl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2012.08.003_bib0005","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.eururo.2011.02.043","article-title":"Natural history of patients presenting biochemical recurrence after radical prostatectomy: some good news?","volume":"59","author":"Guillonneau","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.003_bib0010","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.eururo.2007.01.015","article-title":"Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy","volume":"51","author":"Simmons","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.003_bib0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.eururo.2011.02.026","article-title":"Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence","volume":"59","author":"Boorjian","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.003_bib0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.urology.2006.10.031","article-title":"Role of pelvic lymphadenectomy in prostate cancer management","volume":"69","author":"Sivalingam","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2012.08.003_bib0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","author":"Hovels","year":"2008","journal-title":"Clin Radiol"},{"key":"10.1016\/j.eururo.2012.08.003_bib0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.eururo.2007.09.002","article-title":"EAU guidelines on prostate cancer","volume":"53","author":"Heidenreich","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.003_bib0035","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/01.ju.0000056901.95996.43","article-title":"Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography","volume":"169","author":"Picchio","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.003_bib0040","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1464-410X.2008.07592.x","article-title":"Histological verification of 11C-choline-positron emission\/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer","volume":"102","author":"Schilling","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2012.08.003_bib0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.eururo.2007.03.032","article-title":"Detection of lymph-node metastases with integrated [11C]choline PET\/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy","volume":"52","author":"Scattoni","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.003_bib0050","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/RLU.0b013e31821c9921","article-title":"Colonic FDG uptake pattern in subjects receiving oral contrast with no known or suspected colonic disease","volume":"36","author":"Jadvar","year":"2011","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.eururo.2012.08.003_bib0055","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1464-410X.2009.09191.x","article-title":"[18F]-fluorocholine positron-emission\/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study","volume":"106","author":"Poulsen","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2012.08.003_bib0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2010.10.039","article-title":"EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease","volume":"59","author":"Heidenreich","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.003_bib0065","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.eururo.2011.09.019","article-title":"Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature","volume":"61","author":"Giannarini","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.003_bib0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.eururo.2011.01.015","article-title":"Prospective evaluation of 11C-choline positron emission tomography\/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases","volume":"60","author":"Budiharto","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.003_bib0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00259-009-1253-3","article-title":"Predictive factors of [(11)C]choline PET\/CT in patients with biochemical failure after radical prostatectomy","volume":"37","author":"Giovacchini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.eururo.2012.08.003_bib0080","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00259-011-1867-0","article-title":"Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET\/CT study","volume":"38","author":"Fuccio","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.eururo.2012.08.003_bib0085","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s11307-009-0217-0","article-title":"The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT","volume":"11","author":"Beheshti","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.eururo.2012.08.003_bib0090","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1148\/radiol.09090413","article-title":"18F choline PET\/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients","volume":"254","author":"Beheshti","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.eururo.2012.08.003_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00259-006-0190-7","article-title":"Value of 11C-choline PET and PET\/CT in patients with suspected prostate cancer","volume":"34","author":"Scher","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.eururo.2012.08.003_bib0100","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.eururo.2008.04.030","article-title":"11C-choline positron emission tomography\/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms","volume":"54","author":"Schiavina","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.003_bib0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00259-007-0552-9","article-title":"Evaluation of [(18)F]-choline PET\/CT for staging and restaging of prostate cancer","volume":"35","author":"Husarik","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228381200927X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228381200927X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T14:58:22Z","timestamp":1542812302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030228381200927X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S030228381200927X"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2012.08.003","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}